日本患者醛固酮瘤中体细胞突变患病率研究
该研究采用醛固酮合酶(CYP11B2)免疫组化引导的测序方法,检测东北大学医院接受肾上腺切除术的单侧原发性醛固酮增多症患者的醛固酮瘤(APA)体细胞突变。106个APA中102个(96%)检出相关体细胞突变,KCNJ5突变最常见(73%),女性APA中KCNJ5突变检出率高于男性(95% vs 60%,P < 0.0001)。
要点
- CYP11B2免疫组化引导测序在96%(102/106)的日本APA中检出体细胞突变。
- KCNJ5突变最常见(73%),其次为CACNA1D(14%)、ATP1A1(5%)、ATP2B3(4%)、CACNA1H(1%)。
- 女性APA中KCNJ5突变检出率高于男性(95% vs 60%,P < 0.0001)。
核心结论
- 免疫组化引导测序在超过95%的日本APA中定义了体细胞突变,证实KCNJ5突变在该队列中占主导,且女性患者KCNJ5突变患病率显著更高。
研究设计与样本
- 研究纳入在东北大学医院接受肾上腺切除术的单侧原发性醛固酮增多症患者,基于CYP11B2免疫组化定位,从APA的10%福尔马林固定石蜡包埋组织阳性区域提取基因组DNA,采用直接Sanger测序和靶向下一代测序检测醛固酮驱动基因的体细胞突变。
主要发现
- CYP11B2免疫组化引导测序在106个APA中的102个(96%)检出APA相关体细胞突变。
- KCNJ5体细胞突变为该日本患者队列中最常见的遗传改变(73%)。
- 其他醛固酮驱动基因体细胞突变检出率为CACNA1D(14%)、ATP1A1(5%)、ATP2B3(4%)、CACNA1H(1%),包括2个既往未报告的突变。
- 女性患者APA中KCNJ5突变检出率高于男性患者[95%(36/38)vs 60%(41/68);P < 0.0001]。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Results of previous studies demonstrated clear racial differences in the prevalence of somatic mutations among patients with aldosterone-producing adenoma (APA). For instance, those in East Asian countries have a high prevalence of somatic mutations in KCNJ5, whereas somatic mutations in other aldosterone-driving genes are rare. OBJECTIVES: To determine somatic mutation prevalence in Japanese APA patients using an aldosterone synthase (CYP11B2) immunohistochemistry (IHC)-guided sequencing approach. METHOD: Patients with a unilateral form of primary aldosteronism who underwent adrenalectomy at the Tohoku University Hospital were studied. Based on CYP11B2 immunolocalization of resected adrenals, genomic DNA was isolated from the relevant positive area of 10% formalin-fixed, paraffin-embedded tissue of the APAs. Somatic mutations in aldosterone-driving genes were studied in APAs by direct Sanger sequencing and targeted next-generation sequencing. RESULTS: CYP11B2 IHC-guided sequencing determined APA-related somatic mutations in 102 out of 106 APAs (96%). Somatic KCNJ5 mutation was the most frequent genetic alteration (73%) in this cohort of Japanese patients. Somatic mutations in other aldosterone-driving genes were also identified: CACNA1D (14%), ATP1A1 (5%), ATP2B3 (4%), and CACNA1H (1%), including 2 previously unreported mutations. KCNJ5 mutations were more often detected in APAs from female patients compared with those from male patients [95% (36/38) vs 60% (41/68); P < 0.0001]. CONCLUSION: IHC-guided sequencing defined somatic mutations in over 95% of Japanese APAs. While the dominance of KCNJ5 mutations in this particular cohort was confirmed, a significantly higher KCNJ5 prevalence was detected in female patients. This study provides a better understanding of genetic spectrum of Japanese APA patients.
引用
- Nanba K, Yamazaki Y, Bick N, et al. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients. J Clin Endocrinol Metab. 2020. PMID: 32844168. doi:10.1210/clinem/dgaa595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。